全文获取类型
收费全文 | 642篇 |
免费 | 62篇 |
出版年
2023年 | 3篇 |
2022年 | 4篇 |
2021年 | 13篇 |
2020年 | 6篇 |
2019年 | 3篇 |
2018年 | 9篇 |
2017年 | 4篇 |
2016年 | 17篇 |
2015年 | 23篇 |
2014年 | 29篇 |
2013年 | 31篇 |
2012年 | 44篇 |
2011年 | 35篇 |
2010年 | 34篇 |
2009年 | 22篇 |
2008年 | 43篇 |
2007年 | 26篇 |
2006年 | 37篇 |
2005年 | 28篇 |
2004年 | 25篇 |
2003年 | 27篇 |
2002年 | 23篇 |
2001年 | 20篇 |
2000年 | 16篇 |
1999年 | 15篇 |
1998年 | 7篇 |
1997年 | 9篇 |
1996年 | 4篇 |
1995年 | 9篇 |
1994年 | 4篇 |
1993年 | 5篇 |
1992年 | 13篇 |
1991年 | 12篇 |
1990年 | 7篇 |
1989年 | 4篇 |
1987年 | 3篇 |
1986年 | 12篇 |
1984年 | 7篇 |
1983年 | 4篇 |
1981年 | 4篇 |
1979年 | 4篇 |
1978年 | 4篇 |
1976年 | 4篇 |
1973年 | 6篇 |
1970年 | 5篇 |
1969年 | 3篇 |
1962年 | 2篇 |
1959年 | 4篇 |
1954年 | 2篇 |
1953年 | 2篇 |
排序方式: 共有704条查询结果,搜索用时 31 毫秒
81.
Rengaswami Rajaraman Duane L Guernsey Murali M Rajaraman Selva R Rajaraman 《Cancer cell international》2006,6(1):25-26
We describe the basic tenets of the current concepts of cancer biology, and review the recent advances on the suppressor role
of senescence in tumor growth and the breakdown of this barrier during the origin of tumor growth. Senescence phenotype can
be induced by (1) telomere attrition-induced senescence at the end of the cellular mitotic life span (MLS*) and (2) also by
replication history-independent, accelerated senescence due to inadvertent activation of oncogenes or by exposure of cells
to genotoxins. Tumor suppressor genes p53/pRB/p16INK4A and related senescence checkpoints are involved in effecting the onset
of senescence. However, senescence as a tumor suppressor mechanism is a leaky process and senescent cells with mutations or
epimutations in these genes escape mitotic catastrophe-induced cell death by becoming polyploid cells. These polyploid giant
cells, before they die, give rise to several cells with viable genomes via nuclear budding and asymmetric cytokinesis. This
mode of cell division has been termed neosis and the immediate neotic offspring the Raju cells. The latter inherit genomic
instability and transiently display stem cell properties in that they differentiate into tumor cells and display extended,
but, limited MLS, at the end of which they enter senescent phase and can undergo secondary/tertiary neosis to produce the
next generation of Raju cells. Neosis is repeated several times during tumor growth in a non-synchronized fashion, is the
mode of origin of resistant tumor growth and contributes to tumor cell heterogeneity and continuity. The main event during
neosis appears to be the production of mitotically viable daughter genome after epigenetic modulation from the non-viable
polyploid genome of neosis mother cell (NMC). This leads to the growth of resistant tumor cells. Since during neosis, spindle
checkpoint is not activated, this may give rise to aneuploidy. Thus, tumor cells also are destined to die due to senescence,
but may escape senescence due to mutations or epimutations in the senescent checkpoint pathway. A historical review of neosis-like
events is presented and implications of neosis in relation to the current dogmas of cancer biology are discussed. Genesis
and repetitive re-genesis of Raju cells with transient "stemness" via neosis are of vital importance to the origin and continuous
growth of tumors, a process that appears to be common to all types of tumors. We suggest that unlike current anti-mitotic
therapy of cancers, anti-neotic therapy would not cause undesirable side effects. We propose a rational hypothesis for the
origin and progression of tumors in which neosis plays a major role in the multistep carcinogenesis in different types of
cancers. We define cancers as a single disease of uncontrolled neosis due to failure of senescent checkpoint controls. 相似文献
82.
83.
Subramanian Swaminathan Vanamail Perumal Srividya Adinarayanan Krishnamoorthy Kaliannagounder Ravi Rengachari Jambulingam Purushothaman 《PLoS neglected tropical diseases》2012,6(11)
Background
Monitoring and evaluation guidelines of the programme to eliminate lymphatic filariasis require impact assessments in at least one sentinel and one spot-check site in each implementation unit (IU). Transmission assessment surveys (TAS) that assess antigenaemia (Ag) in children in IUs that have completed at least five rounds of mass drug administration (MDA) each with >65% coverage and with microfilaria (Mf) levels <1% in the monitored sites form the basis for stopping the MDA. Despite its rigour, this multi-step process is likely to miss sites with transmission potential (‘hotspots’) and its statistical assumptions for sampling and threshold levels for decision-making have not been validated. We addressed these issues in a large-scale epidemiological study in two primary health centres in Thanjavur district, India, endemic for bancroftian filariasis that had undergone eight rounds of MDA.Methodology/Principal Findings
The prevalence and intensity of Mf (per 60 µl blood) were 0.2% and 0.004 respectively in the survey that covered >70% of 50,363 population. The corresponding values for Ag were 2.3% and 17.3 Ag-units respectively. Ag-prevalence ranged from 0.7 to 0.9%, in children (2–10 years) and 2.7 to 3.0% in adults. Although the Mf-levels in the survey and the sentinel/spot check sites were <1% and Ag-level was <2% in children, we identified 7 “residual” (Mf-prevalence ≥1%, irrespective of Ag-status in children) and 17 “transmission” (at least one Ag-positive child born during the MDA period) hotspots. Antigenaemic persons were clustered both at household and site levels. We identified an Ag-prevalence of ∼1% in children (equivalent to 0.4% community Mf-prevalence) as a possible threshold value for stopping MDA.Conclusions/Significance
Existence of ‘hotspots’ and spatial clustering of infections in the study area indicate the need for developing good surveillance strategies for detecting ‘hotspots’, adopting evidence-based sampling strategies and evaluation unit size for TAS. 相似文献84.
Biofiltration for treating VOCs: an overview 总被引:1,自引:0,他引:1
Swaminathan Detchanamurthy Peter Alan Gostomski 《Reviews in Environmental Science and Biotechnology》2012,11(3):231-241
In this paper we present a review of Biofiltration, one of the air pollution control technologies (APCT) used to treat volatile organic compounds (VOCs) effectively. It also talks about the history of biofiltration, and also proposes few ideas for the future developments in the biofiltration research pertaining to VOC control. Moreover, the paper also discusses about various important physical, chemical and biological factors which affect the performance of a biofilter both directly and indirectly. This paper will be handier for those who are new to the field of biofiltration research for VOC treatment. 相似文献
85.
Phospholipase D1 plays a key role in TNF-alpha signaling 总被引:1,自引:0,他引:1
Sethu S Mendez-Corao G Melendez AJ 《Journal of immunology (Baltimore, Md. : 1950)》2008,180(9):6027-6034
The primary characteristic features of any inflammatory or infectious lesions are immune cell infiltration, cellular proliferation, and the generation of proinflammatory mediators. TNF-alpha is a potent proinflammatory and immuno-regulatory cytokine. Decades of research have been focused on the physiological/pathophysiological events triggered by TNF-alpha. However, the signaling network initiated by TNF-alpha in human leukocytes is still poorly understood. In this study, we report that TNF-alpha activates phospholipase D1 (PLD1), in a dose-dependent manner, and PLD1 is required for the activation of sphingosine kinase and cytosolic calcium signals. PLD1 is also required for NFkappaB and ERK1/2 activation in human monocytic cells. Using antisense oligonucleotides to reduce specifically the expression of PLD isozymes showed PLD1, but not PLD2, to be coupled to TNF-alpha signaling and that PLD1 is required to mediate receptor activation of sphingosine kinase and calcium transients. In addition, the coupling of TNF-alpha to activation of the phosphorylation of ERK1/2 and the activation of NFkappaB were inhibited by pretreating cells with antisense to PLD1, but not to PLD2; thus, demonstrating a specific requirement for PLD1. Furthermore, use of antisense oligonucleotides to reduce expression of PLD1 or PLD2 demonstrated that PLD1 is required for TNF-alpha-induced production of several important cytokines, such as IL-1beta, IL-5, IL-6, and IL-13, in human monocytes. These studies demonstrate the critical role of PLD1 in the intracellular signaling cascades initiated by TNF-alpha and its functional role for coordinating the signals to inflammatory responses. 相似文献
86.
Varghese B Barriere H Carbone CJ Banerjee A Swaminathan G Plotnikov A Xu P Peng J Goffin V Lukacs GL Fuchs SY 《Molecular and cellular biology》2008,28(17):5275-5287
The ubiquitination of the receptor that mediates signaling induced by the polypeptide pituitary hormone prolactin (PRL) has been shown to lead to the degradation of this receptor and to the ensuing negative regulation of cellular responses to PRL. However, the mechanisms of PRL receptor (PRLr) proteolysis remain largely to be determined. Here we provide evidence that PRLr is internalized and primarily degraded via the lysosomal pathway. Ubiquitination of PRLr is essential for the rapid internalization of PRLr, which proceeds through a pathway dependent on clathrin and the assembly polypeptide 2 (AP2) adaptor complexes. Recruitment of AP2 to PRLr is stimulated by PRLr ubiquitination, which also is required for the targeting of already internalized PRLr to the lysosomal compartment. While mass spectrometry analysis revealed that both monoubiquitination and polyubiquitination (via both K48- and K63-linked chains) occur on PRLr, the results of experiments using forced expression of ubiquitin mutants indicate that PRLr polyubiquitination via K63-linked chains is important for efficient interaction of PRLr with AP2 as well as for efficient internalization, postinternalization sorting, and proteolytic turnover of PRLr. We discuss how specific ubiquitination may regulate early and late stages of endocytosis of PRLr and of related receptors to contribute to the negative regulation of the magnitude and duration of downstream signaling. 相似文献
87.
Srinivasan Rajaraman Andrei V Gribok Nancy J Wesensten Thomas J Balkin Jaques Reifman 《Journal of applied physiology》2008,104(2):459-468
We present a new method for developing individualized biomathematical models that predict performance impairment for individuals restricted to total sleep loss. The underlying formulation is based on the two-process model of sleep regulation, which has been extensively used to develop group-average models. However, in the proposed method, the parameters of the two-process model are systematically adjusted to account for an individual's uncertain initial state and unknown trait characteristics, resulting in individual-specific performance prediction models. The method establishes the initial estimates of the model parameters using a set of past performance observations, after which the parameters are adjusted as each new observation becomes available. Moreover, by transforming the nonlinear optimization problem of finding the best estimates of the two-process model parameters into a set of linear optimization problems, the proposed method yields unique parameter estimates. Two distinct data sets are used to evaluate the proposed method. Results of simulated data (with superimposed noise) show that the model parameters asymptotically converge to their true values and the model prediction accuracy improves as the number of performance observations increases and the amount of noise in the data decreases. Results of a laboratory study (82 h of total sleep loss), for three sleep-loss phenotypes, suggest that individualized models are consistently more accurate than group-average models, yielding as much as a threefold reduction in prediction errors. In addition, we show that the two-process model of sleep regulation is capable of representing performance data only when the proposed individualized model is used. 相似文献
88.
The global impact of the converging dual epidemics of tuberculosis (TB) and human immunodeficiency virus (HIV) is one of the
major public health challenges of our time. The World Health Organization (WHO) reports 9.2 million new cases of TB in 2006
of whom 7.7% were HIV-infected. Tuberculosis is the most common opportunistic infection in HIV-infected patients as well as
the leading cause of death. Further, there has been an increase in rates of drug resistant tuberculosis, including multi-drug
(MDRTB) and extensively drug resistant TB (XDRTB), which are difficult to treat and contribute to increased mortality. The
diagnosis of TB is based on sputum smear microscopy, a 100-year old technique and chest radiography, which has problems of
specificity. Extra-pulmonary, disseminated and sputum smear negative manifestations are more common in patients with advanced
immunosuppression. Newer diagnostic tests are urgently required that are not only sensitive and specific but easy to use in
remote and resource-poor settings. Treatment of HIV-TB co-infection is complex and associated with high pill burden, overlapping
drug toxicities, risk of immune reconstitution inflammatory syndrome (IRIS) and challenges related to adherence. From a programmatic
point of view, screening of all HIV-infected persons for tuberculosis and vice-versa will help identify co-infected patients
who require treatment for both infections. This requires good coordination and communication between the TB and AIDS control
programs, in India. 相似文献
89.
90.